Xinjian Li
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Oncology top 5%
- Immunology top 5%
- Epidemiology top 5%
- Topics
- Cancer, Hypoxia, and Metabolism (11 papers)Autophagy in Disease and Therapy (8 papers)Metabolism, Diabetes, and Cancer (7 papers)
- Journals
- NatureCellNature Communications
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xinjian Li
62 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Biology 3.1k
- Cancer Research 1.9k
- Oncology 573
- Immunology 515
- Epidemiology 484
Countries citing papers authored by Xinjian Li
This map shows the geographic impact of Xinjian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjian Li more than expected).
Fields of papers citing papers by Xinjian Li
This network shows the impact of papers produced by Xinjian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjian Li. The network helps show where Xinjian Li may publish in the future.
Co-authorship network of co-authors of Xinjian Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xinjian Li. A scholar is included among the top collaborators of Xinjian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinjian Li. Xinjian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 44 | |
| 6 | 158 | |
| 7 | 36 | |
| 8 | 115 | |
| 9 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesisbreakdown → | 260 |
| 10 | 1 | |
| 11 | 119 | |
| 12 | 67 | |
| 13 | 132 | |
| 14 | 260 | |
| 15 | 139 | |
| 16 | 45 | |
| 17 | 142 | |
| 18 | 164 | |
| 19 | 185 | |
| 20 | PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesisbreakdown → | 672 |
About Xinjian Li
Xinjian Li is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 66 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (11 papers), Autophagy in Disease and Therapy (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (3.1k citations) and Immunology (515 citations). Xinjian Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhimin Lu, Yan Xia, Xu Qian, Yanhua Zheng, David H. Hawke, Weiwei Yang, Kenneth Aldape, Tony Hunter, Yuhui Jiang and Ji Liang. Their work appears in journals such as Nature, Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.